Looking to publish in JACC-basic To Translational Science? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowJACC: Basic to Translational Science is an open access specialist journal in the JACC family that serves as a forum for translational cardiovascular medicine and aims to accelerate the translation of scientific discoveries into therapies that improve outcomes for patients with or at risk for cardiovascular disease. Areas of interest include pre-clinical research, clinical trials, personalized medicine, novel drugs, devices and biologics, proteomics, genomics and metabolomics, and early phase clinical trial methodology.
Looking to publish in JACC-basic To Translational Science? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
JACC-basic To Translational Science accepts the following article types. Click on an article type to view submission instructions.
Original Research Paper
State-Of-The-Art Papers
Leading Edge Translational Research
Leading Edge Translational Science
Letters To The Editor
Recent Publications
FOXC1 Controls Smooth Muscle Cell Differentiation and Plasticity in Vascular Disease
Urszula Rykaczewska, Bianca E. Suur, Sampath Narayanan, Sofija Sundman, Gaelle Auguste, Quanyi Zhao, Xiang Zhang, Inika Prasad, Åsa Hedman, Mariette Lengquist, Malin Kronqvist, Karl Swärd, Anton Razuvaev, Anders Mälarstig, Per Eriksson, Clint Miller, Thomas Quertermous, Ulf Hedin, Ljubica Matic
Moving Beyond the Hype in Extracellular Vesicle Therapy
Eduardo Marbán
Feasibility of Magnetic Resonance Imaging–Guided Pulmonary Artery Stenting in a Commercial Wide-Bore 0.55-T Scanner
Yixuan Liu, John M. Kelly, Jason Swinning, Yingmin Liu, Matthew Joseph, Ning Jin, Jianing Pang, Florian Maier, Axel J. Krafft, Nathan A. Ooms, Jesse Roll, Joshua Krieger, David C. Gross, Orville Bramwell, Lucien de Mos, Paul Borm, Orlando P. Simonetti, Aimee K. Armstrong
Myocardial Inflammation and Arrhythmogenic Cardiomyopathy
Laura De Michieli, Domenico Corrado
Targeted Intra-Atrial Delivery of GMP-Grade Human Extracellular Vesicles Prevents Inflammation-Driven Postoperative Atrial Fibrillation in Pigs
Noreen Ahmed, Sandrine Parent, Charlotte A. René, Nevena Kovacina, Jennifer St. Amant, Melody Napoleone, Berenice Collet, Saad Kahn, David Courtman, Duncan J. Stewart, Vincent Chan, Darryl R. Davis
Frequently asked questions
How long does it take to publish?
Leading Edge Translational Research and Leading Edge Translational Science submissions are reviewed for interest within seven days of submission. Expedited review requests receive a decision on suitability within 2 days and an initial decision within 14 days.
Reformat to JACC-basic To Translational Science using Livewrite PremiumIs a cover letter required?
A cover letter is required. It must state that the paper is not under consideration elsewhere, that its contents have not been previously published, that all authors have read and approved the manuscript, and disclose any potential conflicts of interest or state that none exist. The corresponding author must be specified. If there are more than 4 authors, each author's contribution must be substantiated in the cover letter. Authors requesting expedited review must include the request and rationale in the cover letter.
Reformat to JACC-basic To Translational Science using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge: USD 4750 for full length articles and USD 1900 for Short Communications (Research Letter), excluding taxes.
Reformat to JACC-basic To Translational Science using Livewrite Premium